Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.
Aussedat G, Maucort-Boulch D, Rey P, Safar V, Karlin L, Elsensohn MH, Bachy E, Lebras L, Favier B, Vantard N, Ghergus D, Golfier C, Sesques P, Lazareth A, Lequeu H, Ferrant E, Salles G, Nicolas-Virelizier E, Ghesquieres H. Aussedat G, et al. Leuk Lymphoma. 2022 Mar;63(3):599-607. doi: 10.1080/10428194.2021.1998483. Epub 2021 Oct 31. Leuk Lymphoma. 2022. PMID: 34720034
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
Aussedat G, Traverse-Glehen A, Stamatoullas A, Molina T, Safar V, Laurent C, Michot JM, Hirsch P, Nicolas-Virelizier E, Lamure S, Regny C, Picquenot JM, Ledoux-Pilon A, Tas P, Chassagne-Clément C, Manson G, Lemal R, Fontaine J, Le Cann M, Salles G, Ghesquières H, Copie-Bergman C, Sarkozy C. Aussedat G, et al. Br J Haematol. 2020 Apr;189(2):244-256. doi: 10.1111/bjh.16331. Epub 2020 Feb 6. Br J Haematol. 2020. PMID: 32030731 Free article.
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Bourbon E, Sesques P, Gossez M, Tordo J, Ferrant E, Safar V, Wallet F, Aussedat G, Maarek A, Bouafia F, Karlin L, Ghergus D, Golfier C, Lequeu H, Lazareth A, Schwiertz V, Viel S, Idlhaj M, Ghesquières H, Monneret G, Bachy E, Venet F. Bourbon E, et al. Among authors: aussedat g. Blood Adv. 2023 Mar 14;7(5):744-755. doi: 10.1182/bloodadvances.2021006563. Blood Adv. 2023. PMID: 35439292 Free PMC article.
Adrenal lymphoma: presentation, management and prognosis.
Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM. Laurent C, et al. Among authors: aussedat g. QJM. 2017 Feb 1;110(2):103-109. doi: 10.1093/qjmed/hcw174. QJM. 2017. PMID: 27795295
One translocation for 2 lymphoid neoplasms.
Aussedat G, Baseggio L. Aussedat G, et al. Blood. 2019 Jan 10;133(2):180. doi: 10.1182/blood-2018-10-877357. Blood. 2019. PMID: 30630847 Free article. No abstract available.
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy.
Sesques P, Karlin L, Massy E, Maarek A, Aussedat G, Lazareth A, Golfier C, Bouafia-Sauvy F, Lequeu H, Ghergus D, Safar V, Ferrant E, Bachy E, Ghesquières H, Confavreux CB, Demangel D, Perrial E, Dumontet C. Sesques P, et al. Among authors: aussedat g. Front Oncol. 2024 Oct 31;14:1436587. doi: 10.3389/fonc.2024.1436587. eCollection 2024. Front Oncol. 2024. PMID: 39544298 Free PMC article.
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.
Lan CL, Belot A, Golfier C, Audin B, Sesques P, Bernier A, Safar V, Ferrant E, Lazareth A, Lequeu H, Karlin L, Ghergus D, Maarek A, Aussedat G, Idlhaj M, Salles G, Cherblanc F, Bachy E, Ghesquieres H. Lan CL, et al. Among authors: aussedat g. Hematol Oncol. 2024 Jul;42(4):e3297. doi: 10.1002/hon.3297. Hematol Oncol. 2024. PMID: 38989917 No abstract available.